Soliman Ashraf T, Yassin Mohamed, Majuid Nadra M S Abdel, Sabt Aml, Abdulrahman Mohamed O, De Sanctis Vincenzo
Department of Pediatrics, Hamad Medical Center, Doha, Qatar.
Department of Hematology, Hamad Medical Center, Doha, Qatar.
Indian J Endocrinol Metab. 2013 Nov;17(6):1046-52. doi: 10.4103/2230-8210.122620.
Thalassemia major patients with repeated blood transfusion have high prevalence of endocrinopathies due to iron overload.
We examined the adrenocortical function in 23 thalassemic patients (10 children and 13 young adults) aged 8-26 years. Serum cortisol and dehydroepiandrosterone sulfate (DHEA-S) concentrations were determined in each subject before blood transfusion both in basal condition and after low dose (LD) (1 μg), followed by standard dose (SD) (250 μg, respectively) with synthetic corticotrophin beta 1-24 ACTH (Synacthen, Ciba). Normal controls were a group of 13 age- and sex-matched normal subjects.
Using a peak total cortisol cutoff level of 550 nmol/L and increments of 200 μg above basal cortisol, adrenal insufficiency (AI) was demonstrated in 8 patients (34.7%) after the LD ACTH and in 2 patients (8.7%) after SD cosyntropin (ACTH) test, but none of the controls. Using a peak total cortisol cutoff level of 420 nmol/L and increments of 200 μg above basal cortisol, AI was demonstrated in 5 patients (21.7%) after the LD ACTH and in 2 patients after SD ACTH test (8.7%), but none of controls. All patients with biochemical AI were asymptomatic with normal serum sodium and potassium concentrations and had no history suggestive of adrenal pathology. The peak cortisol concentrations in thalassemic patients with impaired adrenal function both after 1 μg and 250 μg cosyntropin (294 ± 51 nmol/L and 307 ± 58.6) were significantly lower than those with patients with normal (454 ± 79.7 nmol/L and 546.1 ± 92.2 nmol/L, respectively) and controls (460.2 ± 133.4 nmol/L and 554.3 ± 165.8 nmol/L, respectively). Adolescents and young adults, but not children with thalassaemia, had significantly lower peak cortisol concentration after SD ACTH versus controls. Peak cortisol response to LD ACTH was correlated significantly with peak cortisol response to SD in all patients (r = 0.83, P < 0.0001). In adolescents and young adults with thalassemia, DHEA-S levels before and after LD ACTH stimulation were significantly lower and the cortisol/DHEA-S ratios were significantly higher than the controls.
The use of LD ACTH test diagnoses more adrenal abnormalities versus SD ACTH in thalassemic patients. The relatively high prevalence of AI in thalassemic adolescents and young adults necessitates that these patients have to be investigated for AI before major surgery and those with impaired cortisol secretion should receive stress doses of corticosteroids during the stressful event.
重型地中海贫血患者因反复输血导致铁过载,内分泌疾病患病率较高。
我们检测了23例8至26岁的地中海贫血患者(10名儿童和13名青年)的肾上腺皮质功能。在基础状态下以及静脉注射低剂量(LD)(1μg)和随后的标准剂量(SD)(分别为250μg)合成促肾上腺皮质激素β1-24(赛可同,汽巴)后,于输血前测定每位受试者的血清皮质醇和硫酸脱氢表雄酮(DHEA-S)浓度。正常对照组为13名年龄和性别匹配的正常受试者。
采用总皮质醇峰值截断水平550nmol/L以及基础皮质醇水平以上增加200μg的标准,在LD促肾上腺皮质激素刺激后,8例患者(34.7%)被诊断为肾上腺功能不全(AI),在SD促肾上腺皮质激素(ACTH)试验后,2例患者(8.7%)被诊断为肾上腺功能不全,但对照组均无异常。采用总皮质醇峰值截断水平420nmol/L以及基础皮质醇水平以上增加200μg的标准,在LD促肾上腺皮质激素刺激后,5例患者(21.7%)被诊断为肾上腺功能不全,在SD促肾上腺皮质激素试验后,2例患者(8.7%)被诊断为肾上腺功能不全,但对照组均无异常。所有生化性肾上腺功能不全患者均无症状,血清钠和钾浓度正常,且无肾上腺疾病史。肾上腺功能受损的地中海贫血患者在注射1μg和250μg促肾上腺皮质激素后的皮质醇峰值浓度(分别为294±51nmol/L和307±58.6)显著低于肾上腺功能正常的患者(分别为454±79.7nmol/L和546.1±92.2nmol/L)以及对照组(分别为460.2±133.4nmol/L和554.3±165.8nmol/L)。青少年和青年地中海贫血患者在SD促肾上腺皮质激素刺激后的皮质醇峰值浓度显著低于对照组,但儿童患者无此情况。所有患者中,LD促肾上腺皮质激素刺激后的皮质醇峰值反应与SD促肾上腺皮质激素刺激后的皮质醇峰值反应显著相关(r = 0.83,P < 0.0001)。在青少年和青年地中海贫血患者中,LD促肾上腺皮质激素刺激前后的DHEA-S水平显著降低,皮质醇/DHEA-S比值显著高于对照组。
在地中海贫血患者中,与SD促肾上腺皮质激素试验相比,LD促肾上腺皮质激素试验能诊断出更多的肾上腺异常情况。地中海贫血青少年和青年中肾上腺功能不全的患病率相对较高,因此这些患者在进行大手术前必须接受肾上腺功能不全的检查,而皮质醇分泌受损的患者在应激事件期间应接受应激剂量的皮质类固醇治疗。